. * * window.aa needs to exist and be usable by ANY module's script, * however early it runs - main-nav's script, for one, runs near * the top of

糖心原创

, well before the real search-insights.js * so the download * begins as early as before. Repeat calls share the same downloads, a * failed load is retried on the next call, and the versions / SRI * hashes live only here. * * Algolia Insights is unaffected: window.aa above is still created in * on every page and queues events until search-insights loads. * * window.loadAlgoliaLibs({ priority: 'high' }) (Oct 2026): used by the * /search page, where the first results wait on these libraries. Chrome * gives async scripts low priority, behind images and fonts; this asks * for high instead (fetchpriority). Only the first call for a library * sets its priority - later calls share that download. */ (function (win, doc) { var LIBS = [ { ready: function () { return !!win['algoliasearch/lite']; }, src: 'https://cdn.jsdelivr.net/npm/algoliasearch@5.52.1/dist/lite/builds/browser.umd.js', integrity: 'sha256-I2oYUIvhx1g6l4lTP+yoERbzLIHKzw4AKaBRQPwIeDY=' }, { ready: function () { return !!win.instantsearch; }, src: 'https://cdn.jsdelivr.net/npm/instantsearch.js@4.98.0/dist/instantsearch.production.min.js', integrity: 'sha256-ngmqZk4WBxUw257aMYZayyNBd983INngagv0jI6Ecfs=' } ]; function loadOne(lib, options) { if (lib.ready()) return Promise.resolve(); // One download per library, shared by every caller; reset on // failure so the next call retries just the library that failed. if (lib.pending) return lib.pending; lib.pending = new Promise(function (resolve, reject) { var script = doc.createElement('script'); script.src = lib.src; script.integrity = lib.integrity; script.crossOrigin = 'anonymous'; script.async = true; if (options && options.priority === 'high') script.setAttribute('fetchpriority', 'high'); script.onload = function () { lib.ready() ? resolve() : reject(new Error('Loaded but not available: ' + lib.src)); }; script.onerror = function () { script.remove(); reject(new Error('Could not load ' + lib.src)); }; doc.head.appendChild(script); }); lib.pending.catch(function () { lib.pending = null; }); return lib.pending; } win.loadAlgoliaLibs = function (options) { return Promise.all(LIBS.map(function (lib) { return loadOne(lib, options); })); }; })(window, document); . */ window.hsConversationsSettings = window.hsConversationsSettings || {}; window.hsConversationsSettings.loadImmediately = false; (function (win) { var EVENTS = ['pointerdown', 'keydown', 'touchstart', 'scroll', 'mousemove', 'wheel']; var done = false; /* 19 Oct 2026 - chat widget layout shift (field CLS). Phones fail Core Web Vitals on CLS (p75 ~0.2 site-wide in CrUX for months). Biggest cause found: HubSpot's chat container is fixed to the bottom-right corner and changes size - 100x96 launcher to 282x253 when the welcome message pops up (~5 s after load), and to full screen when a visitor opens the chat. Its top-left corner moves, so Chrome scores it as a layout shift: 0.088 per page view at 360x640 (0.044 at 412x850), on every page. Taps happen inside the chat iframe, so the parent page never sees the input and the open/close shifts count too. Fix: whenever the container's size changes it is made transparent for 400 ms (Chrome doesn't score shifts of invisible elements), then shown again at its new size. Tested on live io1001 at 360x640 in a cookie-less frame: the 0.088 shift no longer appears. The chat itself is unchanged - it just appears 0.4 s later at each resize. Relies on HubSpot's container id; if that changes this does nothing (no error). */ function cloakChatResizes() { var ID = 'hubspot-messages-iframe-container'; function watch(c) { if (c.getAttribute('data-bb-cloak')) return; c.setAttribute('data-bb-cloak', '1'); var last = c.offsetWidth + 'x' + c.offsetHeight, timer = null; new MutationObserver(function () { var size = c.offsetWidth + 'x' + c.offsetHeight; if (size === last) return; last = size; c.style.setProperty('opacity', '0', 'important'); clearTimeout(timer); timer = setTimeout(function () { c.style.removeProperty('opacity'); }, 400); }).observe(c, { attributes: true, attributeFilter: ['style', 'class'], subtree: true, childList: true }); } var found = document.getElementById(ID); if (found) { watch(found); return; } if (!document.body || !('MutationObserver' in win)) return; var mo = new MutationObserver(function () { var c = document.getElementById(ID); if (c) { mo.disconnect(); watch(c); } }); mo.observe(document.body, { childList: true }); setTimeout(function () { mo.disconnect(); }, 30000); } function loadWidget() { var api = win.HubSpotConversations; if (api && api.widget && api.widget.status && api.widget.status().loaded) return; try { cloakChatResizes(); } catch (e) {} if (api && api.widget) api.widget.load(); } function onFirstInteraction() { if (done) return; done = true; EVENTS.forEach(function (type) { win.removeEventListener(type, onFirstInteraction, { passive: true }); }); var start = function () { if (win.HubSpotConversations) loadWidget(); else (win.hsConversationsOnReady = win.hsConversationsOnReady || []).push(loadWidget); }; if ('requestIdleCallback' in win) win.requestIdleCallback(start, { timeout: 1500 }); else setTimeout(start, 200); } EVENTS.forEach(function (type) { win.addEventListener(type, onFirstInteraction, { passive: true }); }); })(window);

糖心原创

Skip to main content
Glial cells

Human iPSC-derived glial cells

Consistent, defined and scalable human iPSC-derived glial cell types for neurodegenerative disease research

Glial cells include astrocytes, microglia, oligodendrocytes, and associated precursor cells that enable the brain to function. Once known as nervenkitt (a German word meaning 鈥渘erve glue鈥�), glial cells are the 鈥済lue鈥� that holds the nervous system together by facilitating neuronal signalling, enabling tissue plasticity, providing neuronal support and axonal integrity, metabolism, and protecting neurons from would-be pathogens [1,2]. 

In recent years, a greater appreciation for the role of glial cells in neuronal homeostasis has helped expose potential therapeutic targets in neurodegenerative disease. Glial cells play a complex, enigmatic role in the development and progression of 础濒锄丑别颈尘别谤鈥檚 disease, Parkinson鈥檚 disease, and others. Many research projects are now focussing on understanding the therapeutic potential of targeting glial cells in neurodegenerative disease [2]. 

With access to a consistent and defined source of human glial cell types, researchers can build the complex, physiologically relevant glial cell culture models that are sorely needed in for drug discovery. Whether co-cultured with neurons, as part of a multi-cellular glial-neuronal culture, or used to build three-dimensional tissue models, ioCells are well suited for tissue and neurodegenerative disease modelling; for drug target identification and validation; as well as drug screening among many other uses. 

Take your research to the next level with our ioCells below.

Human iPSC-based models of glial cells for studying neurodegenerative disease

Explore the implication of glial cells in neurodegenerative diseases in this webinar featuring , Senior Research Investigator, . 

bitbio-oligodendrocyte-like-cells-O4-MBP-immunocytochemistry

Product resources

Frequently Asked Questions (FAQs)

What is the role of glial cells in the nervous system?

Once described as nerve glue, glial cells, including astrocytes, microglia, and oligodendrocytes, were once only seen as the filler that supports and insulates neurons. Glial cells are now known to play a variety of critical roles in neuronal homeostasis, such as facilitating neuronal signalling, enabling tissue plasticity, and regulating metabolism. Growing recognition of their role in neuronal homeostasis has recently exposed them as potential therapeutic targets in neurodegenerative disease.

 

How do human iPSC-derived glial cells support neurodegenerative disease research?

Glial cells are essential for neuronal homeostasis and play a complex role in the progression of neurodegenerative diseases, such as 础濒锄丑别颈尘别谤鈥檚 and Parkinson鈥檚 disease. By providing a source of highly defined, consistent human glial cells at scale, ioCells enable scientists to build physiologically relevant models to investigate therapeutic targets and perform drug screening.

 

Which human iPSC-derived glial cell types are available within 糖心原创鈥檚 portfolio?

糖心原创's ioCells portfolio includes defined, consistent human iPSC-derived astrocytes, microglia, and OPC- and oligodendrocyte-like cells powered by opti-ox. These cryopreserved, post-mitotic cells are available as wild-type controls as well as genetically engineered disease models relevant to neurodegenerative disease research.

Additionally, we have developed a portfolio of CRISPR-Ready ioCells, in which wild-type ioCells have been engineered to include a Cas9 cassette, enabling quick and easy gene perturbations and CRISPR screens in physiologically relevant cells. We also offer a suite of ioTracker Cells, in which wild-type ioCells are engineered to express fluorescent tags for easy tracking and live imaging.

 

Can ioCells be used in multi-cell culture models?

ioCells glial cells are suitable for building complex, multi-cellular models for drug discovery and target validation. These human iPSC-derived cells can be co-cultured with neurons to create glial-neuronal cultures that enable the study of critical interactions, such as myelination or neuroinflammation, within a physiologically relevant human context.

 

What disease-specific models are available within the glial cell portfolio?

糖心原创鈥檚 glial cell portfolio includes human iPSC-derived disease models designed to support the study of genetic risk factors in neurodegeneration. Available cells include ioMicroglia expressing specific variants such as TREM2 R47H, P2RY12, and APOE, which allow scientists to compare functional differences between disease genotypes and their genetically matched wild-type controls. 

 

References

1. J盲kel S, Dimou L. (2017) Glial Cells and Their Function in the Adult Brain: A Journey through the History of Their Ablation. 2017 Feb 13;11:24. doi: . PMCID: PMC5303749  PMID:

2. Hanslik K, Marino K, Ulland T. (2021) Modulation of Glial Function in Health, Aging, and Neurodegenerative Disease. . 2021 Aug 31;15:718324. doi: . PMCID: PMC8439422  PMID:

Related pages

Muscle cells Explore our range of hiPSC-derived muscle cells
Neuronal cells Explore our range of hiPSC-derived neuronal cells
Contact us Talk to us about how our technology could support your research